NCT06315335View on ClinicalTrials.gov

A Study to Assess the Safety and Pharmacokinetics of a Single Dose of UCB9741 in Healthy Caucasian and Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Healthy Participants
Interventions
DRUG

UCB9741

Pharmaceutical form: Solution Participants will receive UCB9741 during the Treatment Period.

DRUG

Placebo

Pharmaceutical form: Solution Participants will receive Placebo during the Treatment Period.

Trial Locations (1)

91206

Up0118 10001, Glendale

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY

NCT06315335 - A Study to Assess the Safety and Pharmacokinetics of a Single Dose of UCB9741 in Healthy Caucasian and Japanese Participants | Biotech Hunter | Biotech Hunter